1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Skin and Soft Tissue Infection Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Antibiotics 1.2.3 Anti-Fungal Agents 1.2.4 Others 1.3 Market by Application 1.3.1 Global Skin and Soft Tissue Infection Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Skin and Soft Tissue Infection Treatment Market Perspective (2017-2028) 2.2 Skin and Soft Tissue Infection Treatment Growth Trends by Region 2.2.1 Skin and Soft Tissue Infection Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Skin and Soft Tissue Infection Treatment Historic Market Size by Region (2017-2022) 2.2.3 Skin and Soft Tissue Infection Treatment Forecasted Market Size by Region (2023-2028) 2.3 Skin and Soft Tissue Infection Treatment Market Dynamics 2.3.1 Skin and Soft Tissue Infection Treatment Industry Trends 2.3.2 Skin and Soft Tissue Infection Treatment Market Drivers 2.3.3 Skin and Soft Tissue Infection Treatment Market Challenges 2.3.4 Skin and Soft Tissue Infection Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Skin and Soft Tissue Infection Treatment Players by Revenue 3.1.1 Global Top Skin and Soft Tissue Infection Treatment Players by Revenue (2017-2022) 3.1.2 Global Skin and Soft Tissue Infection Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Skin and Soft Tissue Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Skin and Soft Tissue Infection Treatment Revenue 3.4 Global Skin and Soft Tissue Infection Treatment Market Concentration Ratio 3.4.1 Global Skin and Soft Tissue Infection Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Skin and Soft Tissue Infection Treatment Revenue in 2021 3.5 Skin and Soft Tissue Infection Treatment Key Players Head office and Area Served 3.6 Key Players Skin and Soft Tissue Infection Treatment Product Solution and Service 3.7 Date of Enter into Skin and Soft Tissue Infection Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Skin and Soft Tissue Infection Treatment Breakdown Data by Type 4.1 Global Skin and Soft Tissue Infection Treatment Historic Market Size by Type (2017-2022) 4.2 Global Skin and Soft Tissue Infection Treatment Forecasted Market Size by Type (2023-2028) 5 Skin and Soft Tissue Infection Treatment Breakdown Data by Application 5.1 Global Skin and Soft Tissue Infection Treatment Historic Market Size by Application (2017-2022) 5.2 Global Skin and Soft Tissue Infection Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Skin and Soft Tissue Infection Treatment Market Size (2017-2028) 6.2 North America Skin and Soft Tissue Infection Treatment Market Size by Type 6.2.1 North America Skin and Soft Tissue Infection Treatment Market Size by Type (2017-2022) 6.2.2 North America Skin and Soft Tissue Infection Treatment Market Size by Type (2023-2028) 6.2.3 North America Skin and Soft Tissue Infection Treatment Market Share by Type (2017-2028) 6.3 North America Skin and Soft Tissue Infection Treatment Market Size by Application 6.3.1 North America Skin and Soft Tissue Infection Treatment Market Size by Application (2017-2022) 6.3.2 North America Skin and Soft Tissue Infection Treatment Market Size by Application (2023-2028) 6.3.3 North America Skin and Soft Tissue Infection Treatment Market Share by Application (2017-2028) 6.4 North America Skin and Soft Tissue Infection Treatment Market Size by Country 6.4.1 North America Skin and Soft Tissue Infection Treatment Market Size by Country (2017-2022) 6.4.2 North America Skin and Soft Tissue Infection Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Skin and Soft Tissue Infection Treatment Market Size (2017-2028) 7.2 Europe Skin and Soft Tissue Infection Treatment Market Size by Type 7.2.1 Europe Skin and Soft Tissue Infection Treatment Market Size by Type (2017-2022) 7.2.2 Europe Skin and Soft Tissue Infection Treatment Market Size by Type (2023-2028) 7.2.3 Europe Skin and Soft Tissue Infection Treatment Market Share by Type (2017-2028) 7.3 Europe Skin and Soft Tissue Infection Treatment Market Size by Application 7.3.1 Europe Skin and Soft Tissue Infection Treatment Market Size by Application (2017-2022) 7.3.2 Europe Skin and Soft Tissue Infection Treatment Market Size by Application (2023-2028) 7.3.3 Europe Skin and Soft Tissue Infection Treatment Market Share by Application (2017-2028) 7.4 Europe Skin and Soft Tissue Infection Treatment Market Size by Country 7.4.1 Europe Skin and Soft Tissue Infection Treatment Market Size by Country (2017-2022) 7.4.2 Europe Skin and Soft Tissue Infection Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size (2017-2028) 8.2 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Type 8.2.1 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Application 8.3.1 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Region 8.4.1 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Skin and Soft Tissue Infection Treatment Market Size (2017-2028) 9.2 Latin America Skin and Soft Tissue Infection Treatment Market Size by Type 9.2.1 Latin America Skin and Soft Tissue Infection Treatment Market Size by Type (2017-2022) 9.2.2 Latin America Skin and Soft Tissue Infection Treatment Market Size by Type (2023-2028) 9.2.3 Latin America Skin and Soft Tissue Infection Treatment Market Share by Type (2017-2028) 9.3 Latin America Skin and Soft Tissue Infection Treatment Market Size by Application 9.3.1 Latin America Skin and Soft Tissue Infection Treatment Market Size by Application (2017-2022) 9.3.2 Latin America Skin and Soft Tissue Infection Treatment Market Size by Application (2023-2028) 9.3.3 Latin America Skin and Soft Tissue Infection Treatment Market Share by Application (2017-2028) 9.4 Latin America Skin and Soft Tissue Infection Treatment Market Size by Country 9.4.1 Latin America Skin and Soft Tissue Infection Treatment Market Size by Country (2017-2022) 9.4.2 Latin America Skin and Soft Tissue Infection Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size (2017-2028) 10.2 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Type 10.2.1 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Application 10.3.1 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Country 10.4.1 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck Skin and Soft Tissue Infection Treatment Introduction 11.1.4 Merck Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) 11.1.5 Merck Recent Developments 11.2 Wockhardt Limited 11.2.1 Wockhardt Limited Company Details 11.2.2 Wockhardt Limited Business Overview 11.2.3 Wockhardt Limited Skin and Soft Tissue Infection Treatment Introduction 11.2.4 Wockhardt Limited Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) 11.2.5 Wockhardt Limited Recent Developments 11.3 Atox Bio Inc. 11.3.1 Atox Bio Inc. Company Details 11.3.2 Atox Bio Inc. Business Overview 11.3.3 Atox Bio Inc. Skin and Soft Tissue Infection Treatment Introduction 11.3.4 Atox Bio Inc. Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) 11.3.5 Atox Bio Inc. Recent Developments 11.4 Durata Therapeutics (Teva) 11.4.1 Durata Therapeutics (Teva) Company Details 11.4.2 Durata Therapeutics (Teva) Business Overview 11.4.3 Durata Therapeutics (Teva) Skin and Soft Tissue Infection Treatment Introduction 11.4.4 Durata Therapeutics (Teva) Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) 11.4.5 Durata Therapeutics (Teva) Recent Developments 11.5 Basilea Pharmaceutica AG 11.5.1 Basilea Pharmaceutica AG Company Details 11.5.2 Basilea Pharmaceutica AG Business Overview 11.5.3 Basilea Pharmaceutica AG Skin and Soft Tissue Infection Treatment Introduction 11.5.4 Basilea Pharmaceutica AG Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) 11.5.5 Basilea Pharmaceutica AG Recent Developments 11.6 Melinta Therapeutics 11.6.1 Melinta Therapeutics Company Details 11.6.2 Melinta Therapeutics Business Overview 11.6.3 Melinta Therapeutics Skin and Soft Tissue Infection Treatment Introduction 11.6.4 Melinta Therapeutics Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) 11.6.5 Melinta Therapeutics Recent Developments 11.7 Takeda Pharmaceutical 11.7.1 Takeda Pharmaceutical Company Details 11.7.2 Takeda Pharmaceutical Business Overview 11.7.3 Takeda Pharmaceutical Skin and Soft Tissue Infection Treatment Introduction 11.7.4 Takeda Pharmaceutical Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) 11.7.5 Takeda Pharmaceutical Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Skin and Soft Tissue Infection Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Antibiotics Table 3. Key Players of Anti-Fungal Agents Table 4. Key Players of Others Table 5. Global Skin and Soft Tissue Infection Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Skin and Soft Tissue Infection Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Skin and Soft Tissue Infection Treatment Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Skin and Soft Tissue Infection Treatment Market Share by Region (2017-2022) Table 9. Global Skin and Soft Tissue Infection Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Skin and Soft Tissue Infection Treatment Market Share by Region (2023-2028) Table 11. Skin and Soft Tissue Infection Treatment Market Trends Table 12. Skin and Soft Tissue Infection Treatment Market Drivers Table 13. Skin and Soft Tissue Infection Treatment Market Challenges Table 14. Skin and Soft Tissue Infection Treatment Market Restraints Table 15. Global Skin and Soft Tissue Infection Treatment Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Skin and Soft Tissue Infection Treatment Revenue Share by Players (2017-2022) Table 17. Global Top Skin and Soft Tissue Infection Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin and Soft Tissue Infection Treatment as of 2021) Table 18. Ranking of Global Top Skin and Soft Tissue Infection Treatment Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Skin and Soft Tissue Infection Treatment Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Skin and Soft Tissue Infection Treatment Product Solution and Service Table 22. Date of Enter into Skin and Soft Tissue Infection Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Skin and Soft Tissue Infection Treatment Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Skin and Soft Tissue Infection Treatment Revenue Market Share by Type (2017-2022) Table 26. Global Skin and Soft Tissue Infection Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Skin and Soft Tissue Infection Treatment Revenue Market Share by Type (2023-2028) Table 28. Global Skin and Soft Tissue Infection Treatment Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Skin and Soft Tissue Infection Treatment Revenue Share by Application (2017-2022) Table 30. Global Skin and Soft Tissue Infection Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Skin and Soft Tissue Infection Treatment Revenue Share by Application (2023-2028) Table 32. North America Skin and Soft Tissue Infection Treatment Market Size by Type (2017-2022) & (US$ Million) Table 33. North America Skin and Soft Tissue Infection Treatment Market Size by Type (2023-2028) & (US$ Million) Table 34. North America Skin and Soft Tissue Infection Treatment Market Size by Application (2017-2022) & (US$ Million) Table 35. North America Skin and Soft Tissue Infection Treatment Market Size by Application (2023-2028) & (US$ Million) Table 36. North America Skin and Soft Tissue Infection Treatment Market Size by Country (2017-2022) & (US$ Million) Table 37. North America Skin and Soft Tissue Infection Treatment Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe Skin and Soft Tissue Infection Treatment Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe Skin and Soft Tissue Infection Treatment Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe Skin and Soft Tissue Infection Treatment Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe Skin and Soft Tissue Infection Treatment Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe Skin and Soft Tissue Infection Treatment Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe Skin and Soft Tissue Infection Treatment Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Skin and Soft Tissue Infection Treatment Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Skin and Soft Tissue Infection Treatment Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Skin and Soft Tissue Infection Treatment Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Skin and Soft Tissue Infection Treatment Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Skin and Soft Tissue Infection Treatment Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Skin and Soft Tissue Infection Treatment Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America Skin and Soft Tissue Infection Treatment Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America Skin and Soft Tissue Infection Treatment Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America Skin and Soft Tissue Infection Treatment Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America Skin and Soft Tissue Infection Treatment Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America Skin and Soft Tissue Infection Treatment Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America Skin and Soft Tissue Infection Treatment Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Skin and Soft Tissue Infection Treatment Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Skin and Soft Tissue Infection Treatment Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Skin and Soft Tissue Infection Treatment Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Skin and Soft Tissue Infection Treatment Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Skin and Soft Tissue Infection Treatment Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Skin and Soft Tissue Infection Treatment Market Size by Country (2023-2028) & (US$ Million) Table 62. Merck Company Details Table 63. Merck Business Overview Table 64. Merck Skin and Soft Tissue Infection Treatment Product Table 65. Merck Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) & (US$ Million) Table 66. Merck Recent Developments Table 67. Wockhardt Limited Company Details Table 68. Wockhardt Limited Business Overview Table 69. Wockhardt Limited Skin and Soft Tissue Infection Treatment Product Table 70. Wockhardt Limited Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) & (US$ Million) Table 71. Wockhardt Limited Recent Developments Table 72. Atox Bio Inc. Company Details Table 73. Atox Bio Inc. Business Overview Table 74. Atox Bio Inc. Skin and Soft Tissue Infection Treatment Product Table 75. Atox Bio Inc. Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) & (US$ Million) Table 76. Atox Bio Inc. Recent Developments Table 77. Durata Therapeutics (Teva) Company Details Table 78. Durata Therapeutics (Teva) Business Overview Table 79. Durata Therapeutics (Teva) Skin and Soft Tissue Infection Treatment Product Table 80. Durata Therapeutics (Teva) Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) & (US$ Million) Table 81. Durata Therapeutics (Teva) Recent Developments Table 82. Basilea Pharmaceutica AG Company Details Table 83. Basilea Pharmaceutica AG Business Overview Table 84. Basilea Pharmaceutica AG Skin and Soft Tissue Infection Treatment Product Table 85. Basilea Pharmaceutica AG Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) & (US$ Million) Table 86. Basilea Pharmaceutica AG Recent Developments Table 87. Melinta Therapeutics Company Details Table 88. Melinta Therapeutics Business Overview Table 89. Melinta Therapeutics Skin and Soft Tissue Infection Treatment Product Table 90. Melinta Therapeutics Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) & (US$ Million) Table 91. Melinta Therapeutics Recent Developments Table 92. Takeda Pharmaceutical Company Details Table 93. Takeda Pharmaceutical Business Overview Table 94. Takeda Pharmaceutical Skin and Soft Tissue Infection Treatment Product Table 95. Takeda Pharmaceutical Revenue in Skin and Soft Tissue Infection Treatment Business (2017-2022) & (US$ Million) Table 96. Takeda Pharmaceutical Recent Developments Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Global Skin and Soft Tissue Infection Treatment Market Share by Type: 2021 VS 2028 Figure 2. Antibiotics Features Figure 3. Anti-Fungal Agents Features Figure 4. Others Features Figure 5. Global Skin and Soft Tissue Infection Treatment Market Share by Application: 2021 VS 2028 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Ambulatory Surgical Centers Case Studies Figure 9. Others Case Studies Figure 10. Skin and Soft Tissue Infection Treatment Report Years Considered Figure 11. Global Skin and Soft Tissue Infection Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Skin and Soft Tissue Infection Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Skin and Soft Tissue Infection Treatment Market Share by Region: 2021 VS 2028 Figure 14. Global Skin and Soft Tissue Infection Treatment Market Share by Players in 2021 Figure 15. Global Top Skin and Soft Tissue Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin and Soft Tissue Infection Treatment as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Skin and Soft Tissue Infection Treatment Revenue in 2021 Figure 17. North America Skin and Soft Tissue Infection Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Skin and Soft Tissue Infection Treatment Market Size Market Share by Type (2017-2028) Figure 19. North America Skin and Soft Tissue Infection Treatment Market Size Market Share by Application (2017-2028) Figure 20. North America Skin and Soft Tissue Infection Treatment Market Size Share by Country (2017-2028) Figure 21. United States Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Skin and Soft Tissue Infection Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Skin and Soft Tissue Infection Treatment Market Size Market Share by Type (2017-2028) Figure 25. Europe Skin and Soft Tissue Infection Treatment Market Size Market Share by Application (2017-2028) Figure 26. Europe Skin and Soft Tissue Infection Treatment Market Size Share by Country (2017-2028) Figure 27. Germany Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Skin and Soft Tissue Infection Treatment Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Skin and Soft Tissue Infection Treatment Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Skin and Soft Tissue Infection Treatment Market Size Share by Region (2017-2028) Figure 37. China Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Skin and Soft Tissue Infection Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Skin and Soft Tissue Infection Treatment Market Size Market Share by Type (2017-2028) Figure 45. Latin America Skin and Soft Tissue Infection Treatment Market Size Market Share by Application (2017-2028) Figure 46. Latin America Skin and Soft Tissue Infection Treatment Market Size Share by Country (2017-2028) Figure 47. Mexico Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Skin and Soft Tissue Infection Treatment Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Skin and Soft Tissue Infection Treatment Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Skin and Soft Tissue Infection Treatment Market Size Share by Country (2017-2028) Figure 53. Turkey Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Merck Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2017-2022) Figure 57. Wockhardt Limited Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2017-2022) Figure 58. Atox Bio Inc. Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2017-2022) Figure 59. Durata Therapeutics (Teva) Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2017-2022) Figure 60. Basilea Pharmaceutica AG Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2017-2022) Figure 61. Melinta Therapeutics Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2017-2022) Figure 62. Takeda Pharmaceutical Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2017-2022) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Merck Wockhardt Limited Atox Bio Inc. Durata Therapeutics (Teva) Basilea Pharmaceutica AG Melinta Therapeutics Takeda Pharmaceutical